Document Detail


Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma.
MedLine Citation:
PMID:  9933659     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) has been shown to improve the diagnostic accuracy in the staging of malignant lymphomas, based on the metabolic signal of the lesions. This study was undertaken to determine the effect of attenuation correction in the detection of nodal and extranodal lesions in the primary staging of malignant lymphomas. Fifty-one untreated patients with either non-Hodgkin lymphoma (NHL, n=29) or Hodgkin's disease (n=22) were retrospectively evaluated. Static FDG-PET imaging of the trunk was performed following administration of 250-350 MBq FDG. Attenuation correction was performed in all patients. Images were reconstructed iteratively with or without transmission scans. Image evaluation was performed independently by two observers, who each examined one set of images (i.e. attenuation-corrected or uncorrected). The final decision as to whether results were discordant was reached by consensus of both observers. Out of 593 evaluated lymph node regions, 187 regions of increased FDG uptake were identified by both techniques. Differences between the readers concerned mainly the anatomical assignment of lesions (n=33) or the status (benign/malignant) of individual lesions (n=24). However, direct comparison of the two sets of images demonstrated very similar lesion contrast on attenuation-corrected and non-attenuation-corrected images. Real differences could be determined only in five regions (neck, 1; mediastinum, 1; upper abdomen, 3). Thirty-seven extranodal lesions (including lung, liver, spleen, bone marrow and soft tissue) were detected by both techniques without significant differences. It is concluded that in this study, attenuation correction did not improve the diagnostic accuracy of FDG-PET in the detection of lymph node or organ involvement during the primary staging of malignant lymphomas. Of more importance seemed to be the experience of the reader regarding the classification of a lesion's status the anatomical assignment, knowledge of physiological uptake and artefacts, and systematic and skillful examination of all regions scanned.
Authors:
J Kotzerke; A Guhlmann; F Moog; N Frickhofen; S N Reske
Related Documents :
16856579 - Necessity of a uniform start for scanning after fdg injection in brain pet study.
3665979 - Gallium-67 imaging in the diagnosis of blastomycosis.
15909489 - The effect of oral contrast on large bowel activity in fdg-pet/ct.
19205699 - Head and neck squamous cell carcinoma (hnscc)--detection of synchronous primaries with ...
19401059 - Pet/ct and occult primary tumors.
20634769 - [18f] fdg pet/ct in patients with fever of unknown origin: a local experience.
17940249 - Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxid...
3351239 - Evaluation of the humpback scaphoid by computed tomography in the longitudinal axial pl...
17895799 - Preoperative evaluation of lower extremity arteries for free fibula transfer using mdct...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  European journal of nuclear medicine     Volume:  26     ISSN:  0340-6997     ISO Abbreviation:  Eur J Nucl Med     Publication Date:  1999 Jan 
Date Detail:
Created Date:  1999-02-25     Completed Date:  1999-02-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7606882     Medline TA:  Eur J Nucl Med     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  31-8     Citation Subset:  IM    
Affiliation:
Department of Nuclear Medicine, University of Ulm, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Child
Female
Fluorine Radioisotopes / diagnostic use*
Fluorodeoxyglucose F18 / diagnostic use*
Hodgkin Disease / pathology,  radionuclide imaging*
Humans
Image Processing, Computer-Assisted
Lymphoma, Non-Hodgkin / pathology,  radionuclide imaging*
Male
Middle Aged
Neoplasm Staging
Radiopharmaceuticals / diagnostic use*
Tomography, Emission-Computed / methods*
Chemical
Reg. No./Substance:
0/Fluorine Radioisotopes; 0/Radiopharmaceuticals; 63503-12-8/Fluorodeoxyglucose F18

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A PET study of 18FDG uptake in soft tissue masses.
Next Document:  Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in th...